Paul Fronstin, director of Health Benefits Research at EBRI, discussed ERISA and trends in employer self-insurance during a ...

The menopause market is projected to increase at a CAGR of 5.10% between 2025 – 2033, with North America making up 4.9% ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

New data suggests clinicians may be slower to recognize sepsis in people with pulmonary arterial hypertension.

Whether this proposed rule actually has any impact remains to be seen, especially with a new administration led by Donald ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Greg Baker, CEO of AffirmedRx, shared with MHE editors how the company is addressing ongoing challenges in the pharmacy ...

The Institute for Clinical and Economic Review (ICER) has announced plans to assess the clinical efficacy and value of ...

After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked ...

Attruby (acoramidis) is a small molecule approved to treat adults with transthyretin amyloid cardiomyopathy. It will have a ...

President-elect Donald Trump announced last Thursday, Nov. 14, that Kennedy, 70, was his pick to head the Department of ...

Prescription of Neurontin (gabapentin) and other gabapentinoids has increased partly because they are viewed as a safer ...